Literature DB >> 23652030

A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults.

Brian W Allwood1, Landon Myer, Eric D Bateman.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major public health concern, accounting for 3 million deaths annually, 90% of which occur in low- and middle-income countries. Pulmonary tuberculosis (PTB) as a contributory factor in the aetiology of COPD is under debate, with most epidemiologic evidence suggesting a positive association.
OBJECTIVES: To compile a systematic review of evidence for an association between PTB and the development of chronic airflow obstruction (CAO).
METHODS: We performed a systematic review of original English-language, peer-reviewed literature using the PubMed/MEDLINE database. CAO was defined by spirometry [FEV1:FVC ratio <0.70 or <LLN (lower limit of normal) for age].
RESULTS: Nineteen studies (1 case series, 3 case-control studies, 4 cohort studies, 8 single-centre cross-sectional studies and 3 multi-centre cross-sectional studies) met the eligibility criteria. All but 2 reported a positive association between PTB and CAO. Three of 4 large population-based surveys (n = 4,291-8,066) confirmed a significant association between PTB and CAO (OR 1.37 - 2.94). A formal meta-analysis was not possible owing to marked heterogeneity between studies.
CONCLUSIONS: This systematic review confirms evidence for a positive association between a past history of tuberculosis and the presence of CAO. The association is independent of cigarette smoking. Causality is likely but cannot be assumed.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23652030     DOI: 10.1159/000350917

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  40 in total

1.  Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya.

Authors:  Engi F Attia; Elizabeth Maleche-Obimbo; T Eoin West; Lilian Ndukwe-Wambutsi; Catherine Kiptinness; Anthony Cagle; Christine J McGrath; Celestine K Mugambi; Neveen G El Antouny; Sherry Eskander; Michael H Chung; Kristina Crothers
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

Review 2.  Remembering the Host in Tuberculosis Drug Development.

Authors:  Daniel J Frank; David J Horne; Noton K Dutta; Moagi Tube Shaku; Rajhmun Madensein; Thomas R Hawn; Adrie J C Steyn; Petros C Karakousis; Bavesh Davandra Kana; Graeme Meintjes; Barbara Laughon; Zaid Tanvir
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

3.  Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans.

Authors:  Engi F Attia; Kathleen A McGinnis; Laura C Feemster; Kathleen M Akgün; Adeel A Butt; Christopher J Graber; Michael J Fine; Matthew B Goetz; Maria C Rodriguez-Barradas; Margaret A Pisani; Hilary A Tindle; Sheldon T Brown; Guy W Soo Hoo; David Rimland; Cynthia L Gibert; Laurence Huang; Matthew S Freiberg; Catherine L Hough; Kristina Crothers
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

4.  Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis.

Authors:  Florian M Marx; Ted Cohen; Nicolas A Menzies; Joshua A Salomon; Grant Theron; Reza Yaesoubi
Journal:  Lancet Glob Health       Date:  2020-09       Impact factor: 26.763

Review 5.  Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update.

Authors:  Mohamed Sabeer Abdool-Gaffar; Gregory Calligaro; Michelle Lianne Wong; Clifford Smith; Umesh Gangaram Lalloo; Coenraad Frederik Nicolaas Koegelenberg; Keertan Dheda; Brian William Allwood; Akhter Goolam-Mahomed; Richard Nellis van Zyl-Smit
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

Review 6.  Bronchiectasis and other chronic lung diseases in adolescents living with HIV.

Authors:  Engi F Attia; Robert F Miller; Rashida A Ferrand
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

7.  Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.

Authors:  Jamilah Meghji; Maia Lesosky; Elizabeth Joekes; Peter Banda; Jamie Rylance; Stephen Gordon; Joseph Jacob; Harmien Zonderland; Peter MacPherson; Elizabeth L Corbett; Kevin Mortimer; Stephen Bertel Squire
Journal:  Thorax       Date:  2020-02-26       Impact factor: 9.139

8.  Tuberculosis associates with both airflow obstruction and low lung function: BOLD results.

Authors:  André F S Amaral; Sonia Coton; Bernet Kato; Wan C Tan; Michael Studnicka; Christer Janson; Thorarinn Gislason; David Mannino; Eric D Bateman; Sonia Buist; Peter G J Burney
Journal:  Eur Respir J       Date:  2015-06-25       Impact factor: 16.671

9.  Lung Function and Respiratory Symptoms after Tuberculosis in an American Indian Population. The Strong Heart Study.

Authors:  Martha Powers; Tiffany R Sanchez; Thomas K Welty; Shelley A Cole; Elizabeth C Oelsner; Fawn Yeh; Joanne Turner; Marcia O'Leary; Robert H Brown; Max O'Donnell; David Lederer; Ana Navas-Acien
Journal:  Ann Am Thorac Soc       Date:  2020-01

10.  Most Early-Treated Children With Perinatally Acquired HIV Have Preserved Lung Function at School Age.

Authors:  Engi F Attia; Hellen Moraa; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Laurén A Gómez; Sarah Rylance; Rumbidzayi Vundla; Rashida A Ferrand; Catherine J Karr; Grace C John-Stewart; Sarah F Benki-Nugent
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.